Overview
Manuel Cano practices practicing medicine in Cordoba, Spain.
His clinical expertise encompasses PIK3CA-Related Overgrowth Spectrum, Colorectal Cancer, and Pancreatic Cancer.
He is actively involved in clinical research, co-authoring 24 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Manuel T. Cano
Is Manuel T. Cano a top-rated expert for PIK3CA-Related Overgrowth Spectrum?
MediFind is an objective health platform that identifies experts based on real-world data. Manuel T. Cano is classified as an Experienced expert for PIK3CA-Related Overgrowth Spectrum, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Manuel T. Cano participate in research or clinical trials?
Yes. Manuel T. Cano has published 24 articles and abstracts on conditions like PIK3CA-Related Overgrowth Spectrum. You can view a list of Manuel T. Cano's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Colorectal CancerMr. Cano isExperienced. Learn about Colorectal Cancer.
- Pancreatic CancerMr. Cano isExperienced. Learn about Pancreatic Cancer.
- PIK3CA-Related Overgrowth SpectrumMr. Cano isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.